| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.95B | 19.52B | 12.98B | -21.64B | 46.50B | 40.65B |
| Gross Profit | 22.95B | 19.52B | 2.37B | 14.29B | 46.50B | 40.65B |
| EBITDA | -5.59B | 635.00M | -204.00M | 1.00B | 2.58B | 169.00M |
| Net Income | 1.30B | 688.00M | -179.00M | -570.00M | 1.98B | 45.00M |
Balance Sheet | ||||||
| Total Assets | 310.63B | 327.39B | 301.58B | 401.79B | 468.25B | 443.81B |
| Cash, Cash Equivalents and Short-Term Investments | 53.68B | 58.18B | 4.07B | 64.31B | 108.25B | 109.00B |
| Total Debt | 4.27B | 5.00B | 4.92B | 6.67B | 12.23B | 11.07B |
| Total Liabilities | 301.25B | 318.08B | 292.03B | 387.60B | 441.88B | 419.15B |
| Stockholders Equity | 9.26B | 9.19B | 7.55B | 10.76B | 26.18B | 24.59B |
Cash Flow | ||||||
| Free Cash Flow | -116.00M | 711.00M | 799.00M | 2.75B | -1.91B | -2.97B |
| Operating Cash Flow | -61.00M | 762.00M | 864.00M | 2.85B | -1.80B | -2.85B |
| Investing Cash Flow | 447.00M | 300.00M | -2.00B | 616.00M | -54.00M | -139.00M |
| Financing Cash Flow | -1.48B | -1.75B | -3.24B | -1.83B | 300.00M | -778.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $34.88B | 9.00 | 17.81% | ― | 16.68% | -28.54% | |
78 Outperform | $38.74B | 11.36 | 20.07% | 1.55% | 7.11% | 22.52% | |
76 Outperform | $19.54B | 12.95 | 13.74% | 3.46% | 12.33% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | $11.35B | 8.32 | 14.42% | 5.86% | -6.19% | ― | |
60 Neutral | $46.42B | 15.42 | 7.68% | 2.03% | -23.02% | 52.43% | |
40 Underperform | $13.76B | -17.35 | -41.33% | 2.19% | 7.70% | -155.12% |
On December 10, 2025, Aegon announced its strategic plan to relocate its head office and legal seat to the US, renaming itself Transamerica Inc. by January 1, 2028. This move aims to strengthen its position in the US life insurance market, which represents 70% of its operations. The transition involves a strategic review of Aegon UK, a reinsurance transaction to reduce capital employed, and a new share buyback program. The relocation will incur an estimated one-time cost of EUR 350 million, with the company planning to report under US GAAP by 2027. This decision is expected to have significant organizational implications, particularly for its head office in the Netherlands, and requires shareholder approval in 2026.
Aegon Ltd. reported a strong third quarter in 2025, with an operating capital generation of EUR 340 million and cash capital at holding of EUR 1.9 billion. The company successfully sold 12.5 million shares in a.s.r. for EUR 700 million and is on track to meet its financial targets for the year. Despite net outflows in its UK platform business, Aegon saw significant growth in its US Strategic Assets, with a 39% increase in Individual Life sales and expanded market share in the World Financial Group. The company remains well-capitalized and anticipates further strategic updates at its upcoming Capital Markets Day.
On November 3, 2025, Aegon announced changes to its Board of Directors, with David Herzog set to succeed William Connelly as Chairman on November 13, 2025. Connelly will retire from his position on the same date. Additionally, Aegon plans to propose Leni Boeren as a new board member at the 2026 Annual General Meeting. Boeren brings extensive experience from her roles in the financial services industry, including positions at Kempen Capital Management and Robeco Groep. These changes are expected to support Aegon’s strategic goals and ongoing transformation efforts.